At a press conference on 29 January, the Dutch authorities set out the broad outlines of the procedure for the relocation of the European Medicines Agency (EMA). They announced that they had, that day, signed the lease for temporary offices prior to moving to permanent premises.
“The physical relocation of EMA to a new host country is the single biggest challenge EMA has ever had to deal with since its establishment”, stated Guido Rasi, Executive Director of the Agency, highlighting the...